ClinicalTrials.Veeva

Menu

Peri-device Leakage Closure After LAAO

C

Cardiovascular Center Frankfurt

Status

Completed

Conditions

Atrial Fibrillation
Leakage of Cardiac Device
Stroke
Bleeding

Treatments

Device: Peri-device leakage closure after left atrial appendage occlusion

Study type

Observational

Funder types

Other

Identifiers

NCT04590898
CVC-002

Details and patient eligibility

About

The investigators thought to evaluate the safety and feasibility of peri-device leakage closure after left atrial appendage occlusion (LAAO, either surgical or interventional) with different devices.

Full description

The global burden of atrial fibrillation (AF) is high and thromboembolic stroke may be one of the fatal complications. Oral anticoagulation has been the mainstay therapy for decades to mitigate stroke risk. However, in poor candidates for long-term anticoagulation non-pharmacological stroke prevention with percutaneous left atrial appendage occlusion (LAAO) is a considerable treatment option. LAA shape and size varies widely and incomplete LAA closure or new leaks, due to LAA remodeling after the procedure, are observed in up to 30% of patients. Those leaks may cause turbulent flow and increase the risk for thrombus formation and subsequent thromboembolic events. However, the clinical significance after percutaneous LAAO has yet to be determined.

If significant leaks are present, patients usually remain on oral anticoagulation. In very few cases, an interventional approach is used to close peri-device leaks.

This is the first systematic study, trying to include a respectable number of patients who underwent peri-device leakage closure after LAAO. In this multi-center, collaborative study the investigators aim to identify different peri-device leak closure strategies with associated clinical outcomes and evaluate safety and feasibility of the procedure.

Enrollment

85 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients after interventional or surgical left atrial appendage occlusion with severe leakage, who underwent interventional peri-device leakage closure

Exclusion criteria

  • n/a

Trial design

85 participants in 1 patient group

significant peri-device leakage after LAA occlusion
Description:
Peri-device leakage closure after left atrial appendage occlusion
Treatment:
Device: Peri-device leakage closure after left atrial appendage occlusion

Trial contacts and locations

16

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems